CompletedNCT03800368
Official study title12-week Aerobic-Anaerobic Transition Exercise Intervention and Overnight Sleep-dependent Procedural Memory Consolidation in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaInterventional studyAges 18–55
- Countries
- Sponsor
- The University of Hong Kong
CompletedNCT01077687
This study has finished and is no longer accepting participants.
In TaipeiSchizophreniaObservational studyAges 16–90
- Countries
- Taiwan
- Sponsor
- National Taiwan University Hospital
CompletedNCT03140475
This study has finished and is no longer accepting participants.
Multiple locations, including GrenobleSchizophreniaObservational studyAges 18–65
- Countries
- France
- Sponsor
- Versailles Hospital
CompletedNCT04069988
Official study titleExploring the Effect of Baduanjin on the Metabolic Parameters and Body Mass Index of People With Schizophrenia: A Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In TaipeiSchizophreniaBehavioural studyAges 20–65
- Countries
- Taiwan
- Sponsor
- National Yang Ming Chiao Tung University
CompletedNCT06440200
Official study titleApplying Group Game-based Activities to Improve the Health of Patients With Chronic Mental Illness
This study has finished and is no longer accepting participants.
In TaipeiSchizophreniaBehavioural studyAges 18+
- Countries
- Taiwan
- Sponsor
- National Taiwan University Hospital
CompletedNCT07453355
Official study titleThe Role of Expressive Arts Therapy in Strengthening Hope in Individuals With Schizophrenia: A Randomized Controlled Trial (EAT-HOPE)
This study has finished and is no longer accepting participants.
In AtakentSchizophreniaBehavioural studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Ondokuz Mayıs University
TerminatedNCT01576640
Official study titleAn Open Trial of Relapse Prevention Therapy for Smokers With Schizophrenia
This study ended early.
In BostonSchizophrenia, AddictionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT02151656
What is this study about?Researchers compared F17464 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including NîmesSchizophreniaMedication studyAges 18–64
- Countries
- France, Hungary, Latvia, + 2 others
- Sponsor
- Pierre Fabre Medicament
CompletedNCT02166918
Official study titleMulticenter Study on Factors Influencing Real-life Social Functioning of People With a Diagnosis of Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including NaplesSchizophreniaObservational studyAges 18–65
- Countries
- Italy
- Sponsor
- University of Campania Luigi Vanvitelli
CompletedNCT04027634
Official study titleFeasibility and Preliminary Effect of Baduanjin Program for People Diagnosed With Schizophrenia: A Pilot Randomized Controlled Trial
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaInterventional studyAges 20–65
- Countries
- Sponsor
- National Yang Ming Chiao Tung University
CompletedNCT01312649
Official study titleFeeling of Being in Control of One's Own Action: Which Mechanisms in Healthy Volunteers and in Mental Diseases
This study has finished and is no longer accepting participants.
In StrasbourgSchizophrenia, BipolarityBehavioural studyAges 18–55
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
CompletedNCT01779700
What is this study about?This study evaluated the safety and effectiveness of Fingolimod for people with schizophrenia.
This study has finished and is no longer accepting participants.
In IndianapolisSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Indiana University